Search Results 1081-1090 of 18490 for Prednisone

1. Publications - Aleksandra Kukla, M.D. - Mayo Clinic

   Ten-year outcome after rapid discontinuation of prednisone in adult primary kidney transplantation Clinical Journal of the American Society of Nephrology.

2. A Study to Evaluate CB-839 HCl in Combination With Carfilzomib and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma - Mayo Clinic

   EXCEPTION: Patients may be on chronic steroids (maximum dose 10 mg/day prednisone equivalent) if they are being given for disorders other than myeloma; e.g. ...

3. Pramipexole (oral route) - Mayo Clinic

   Pramipexole is used to treat Parkinson disease. It may be used alone or in combination with other medicines (eg, levodopa). Pramipexole is a dopamine agonist ...

4. Study of Durvalumab + Tremelimumab With Chemotherapy or Durvalumab With Chemotherapy or Chemotherapy Alone for Patients With Lung Cancer (POSEIDON). - Mayo Clinic

   Systemic corticosteroids at physiologic doses not to exceed 10 mg/day of prednisone or its equivalent;; Steroids as premedication for hypersensitivity ...

5. Rare Disease of Blood Vessels Often Undiagnosed in Early Stages - Mayo Clinic News Network

   Corticosteroids, typically prednisone, are commonly prescribed, because they are effective at suppressing inflammation. Other immunosuppressive drugs may ...

6. AERD Biomarkers to Determine Feasibility of Medical Therapy De-escalation - Mayo Clinic

   Patients who use oral prednisone within 14 days of diagnostic testing. Inability to complete or tolerate aspirin therapy for 12 months. Previous use of ...

7. Study to Assess the Effectiveness and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone to Treat Patients with Previously Treated Non-Hodgkins Lymphoma - Mayo Clinic

   Corticosteroid therapy started at least 7 days prior to study entry (prednisone ≤ 10 mg daily or equivalent) is allowed as clinically warranted. Topical or ...

8. Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma - Mayo Clinic

   Systemic corticosteroids at physiologic doses not to exceed 10mg/day of Prednisone or its equivalent. Known allergy or hypersensitivity to any of the IMPs ...

9. A Study of Subcutaneous Abatacept to Treat Diffuse Cutaneous Systemic Sclerosis - Mayo Clinic

   Oral corticosteroids (≤ 10 mg/day of prednisone or equivalent) and NSAIDs are permitted if the patient is on a stable dose regimen for. 2 weeks prior to and ...

10. Methylene blue (intravenous route) - Side effects & uses - Mayo Clinic

    Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...